Strategies for Artificial Intelligence in Healthcare : Generative Ai, Predictive Analytics, and the Future of Digital Medicine
Idioma: inglés
Editorial: Taylor & Francis Okt 2026, 2026
- Tapa dura
- Nuevo

Librería: AHA-BUCH GmbH, Einbeck, AlemaniaAHA-BUCH GmbH
Vendedor de IberLibro desde 14 de agosto de 2006
Condición: Nuevo
EUR 276,00
Cantidad disponible: 2 disponibles
Añadir al carritoDescripción del artículo del vendedor
Neuware - Strategies for Artificial Intelligence in Healthcare sheds light on the ever-changing world of Artificial Intelligence (AI) within the healthcare industry.As AI technology rapidly advances, the healthcare industry is becoming its most significant and impactful beneficiary. From the authors' viewpoint, AI is revolutionizing healthcare with the promise of improving patient outcomes, lowering costs, and increasing access and efficiency. The use of AI in healthcare is not a new concept. In fact, it has been around for decades, but it is only in recent years that its potential has been fully realized. From the development of new surgical techniques to the use of telemedicine for remote patient care, technology has revolutionized the way healthcare is delivered. With the rise of big data and cloud computing, AI will be an essential toolkit for healthcare professionals, enabling them to harness the immense data power in ways that were previously unimaginable. With real-world case studies, practical applications, and purpose methods, Strategies for Artificial Intelligence in Healthcare is the ultimate guide to navigating the modern healthcare industry with AI. The second edition provides up-to-date material and refreshes and updates case studies.Whether you're an experienced healthcare professional wanting to stay up to date or simply curious about the latest technology, this book offers unique and valuable insights for the future of healthcare with Artificial Intelligence by its side.…
N° de ref. del artículo 9781041117964
- Título
- Strategies for Artificial Intelligence in Healthcare : Generative Ai, Predictive Analytics, and the Future of Digital Medicine
- Autor
- Frank Papay
- Editorial
- Taylor & Francis Okt 2026
- Año de publicación
- 2026
- Estado
- Neu
- Encuadernación
- Buch
- Idioma
- inglés
- ISBN 10
- 1041117965
- ISBN 13
- 9781041117964
- Edición
- 2ª Edición
- Peso del artículo
- 667 gramos
- Dimensiones
- 254x178x16 mm
Strategies for Artificial Intelligence in Healthcare sheds light on the ever-changing world of Artificial Intelligence (AI) within the healthcare industry.
As AI technology rapidly advances, the healthcare industry is becoming its most significant and impactful beneficiary. From the authors’ viewpoint, AI is revolutionizing healthcare with the promise of improving patient outcomes, lowering costs, and increasing access and efficiency. The use of AI in healthcare is not a new concept. In fact, it has been around for decades, but it is only in recent years that its potential has been fully realized. From the development of new surgical techniques to the use of telemedicine for remote patient care, technology has revolutionized the way healthcare is delivered. With the rise of big data and cloud computing, AI will be an essential toolkit for healthcare professionals, enabling them to harness the immense data power in ways that were previously unimaginable. With real-world case studies, practical applications, and purpose methods, Strategies for Artificial Intelligence in Healthcare is the ultimate guide to navigating the modern healthcare industry with AI. The second edition provides up-to-date material and refreshes and updates case studies.
Whether you're an experienced healthcare professional wanting to stay up to date or simply curious about the latest technology, this book offers unique and valuable insights for the future of healthcare with Artificial Intelligence by its side.
“Sinopsis” puede pertenecer a otra edición de este título.
Acerca del autor
Dr. Frank A. Papay, MD, MS, DSc(hon), FACS, FAAP, FNAI, is a physician–executive, surgeon–scientist, inventor, and healthcare systems innovator whose career spans more than three decades at Cleveland Clinic (Cleveland, Ohio, USA), one of the world’s leading academic health systems. He currently serves as Chief Clinical Business Development Officer of Cleveland Clinic Enterprise and former Chairman of Dermatology and Plastic Surgery Institute, where he advises enterprise leadership on growth strategy, innovation portfolio governance, translational commercialization, and AI-enabled care delivery across a $16B+ global healthcare organization.
Dr. Papay is internationally recognized for pioneering work at the intersection of advanced surgery, medical technology, and artificial intelligence. As lead surgeon for America’s first total face transplant, he helped establish the clinical, ethical, and regulatory framework for vascularized composite allotransplantation in the United States. His career includes numerous surgical “firsts,” including novel neuromodulation approaches for chronic pain and migraine, robotic endoscopic nerve reconstruction, and minimally invasive skull-base procedures that replaced high-morbidity open operations.
A prolific innovator, Dr. Papay is an inventor on 40+ issued U.S. patents and 70+ provisional patents spanning surgical devices, digital platforms, neuromodulation technologies, and AI-assisted systems. He has founded and advised multiple venture-backed healthcare companies, guiding technologies from concept through first-in-human trials, regulatory pathways, and institutional capital raises. His experience includes collaboration with venture capital, private equity, and sovereign-aligned investment platforms focused on scaling healthcare innovation globally.
A central focus of his recent work is the integration of artificial intelligence into clinical operations, surgical navigation, and healthcare system performance. Dr. Papay is Co-Founder of BrainX.AI, a global consortium developing machine learning systems for healthcare applications, including surgical intelligence, predictive analytics, and AI-driven decision support. His work emphasizes responsible AI adoption, clinical governance, and translating data science into measurable improvements in patient outcomes, operational efficiency, and system scalability.
Dr. Papay has authored or co-authored more than 260 peer-reviewed scientific publications and multiple foundational scholarly texts. His books include Reconstructive Allotransplantation, a landmark reference in composite tissue transplantation; Virtual Surgical Planning in Surgery, advancing digital precision surgery; Voices of Innovation: Essays on Artificial Intelligence in Healthcare; and Artificial Intelligence Strategies in Healthcare, where he contributes leadership perspectives on AI governance, clinical integration, and system transformation.
He is a Fellow of the National Academy of Inventors and recipient of the Cleveland Clinic’s prestigious Sones Centennial Innovation Award, among many national and international honors. Across his clinical, academic, and executive roles, Dr. Papay’s work bridges medicine, engineering, and AI, shaping how intelligent technologies are responsibly deployed to build the next generation of healthcare delivery systems worldwide.
Dr. Piyush Mathur, MD, FCCM, FASA FAMIA, is a Staff Anesthesiologist and Critical Care Physician at Cleveland Clinic, Ohio, USA, with more than 20 years of experience as a clinician. He is the Innovation Lead for the Department of Anesthesiology, Cleveland Clinic.
He has also served in the role of the Quality Improvement Officer and Chair, Compliance Committee, Anesthesiology Institute for more than a decade. He completed his medical school training in India at the Armed Forces Medical College (AFMC, Pune), followed by residency in Anesthesiology and a fellowship in Critical Care at Cleveland Clinic.
He subsequently completed a one-year quality fellowship at Cleveland Clinic. He has completed training in computer programming, machine learning, and deep learning. He is the Past Program Director of the Anesthesiology Critical Care fellowship program at Cleveland Clinic. A recognized leader in critical care, quality, education, and artificial intelligence applications in healthcare, he has led many of the local and national programs, including serving as the chair of the post-graduate education and coding and documentation committees of the Society of Critical Care Medicine (SCCM).
He is currently a member of the CPT Editorial Advisory Committee, AMA (American Medical Association) and a primary advisor to SCCM. Trained in computer programming, machine learning, and deep learning, he is the founder of BrainX, an AI in healthcare application research and development company. He also founded one of the largest groups for machine learning in healthcare, BrainX Community. He has focused his research on applications of artificial intelligence (AI) in healthcare for many years. He is a leader in quality and patient safety who has innovated and successfully implemented many algorithms and tools in electronic health records such as difficult airway identification (EPIC), anesthesia awareness alert (DSS, Talis), and antibiotic alert (ACG, Talis).
Recipient of multiple innovation awards at Cleveland Clinic, he is leading innovation efforts in integrating machine learning and artificial intelligence in healthcare. Current projects include AIDE (Artificial Intelligence Diagnosis Engine), SALUS (robotic artificial intelligence patient safety system), and BRAINS (Biologically Relational Artificial Intelligence Networking System).
He is a recipient of numerous local and international awards including the Institute of Healthcare Improvement (IHI) Permanente Award and the prestigious Presidential Citation from the Society of Critical Care Medicine (SCCM). He has made numerous local, national, and international presentations and publications in the fields of anesthesiology, critical care, quality, education, and artificial intelligence applications in healthcare. For his work in the field of AI and healthcare, he was awarded the AI Clinician of the Year at the 2025 AIMed Conference.
“Acerca de” puede pertenecer a otra edición de este título.
AHA-BUCH GmbH
Einbeck, Alemania
Vendedor de IberLibro desde 14 de agosto de 2006
Tarifas de envío de Alemania a Estados Unidos de America
| Artículo | De 7 a 10 días hábiles | De 5 a 7 días hábiles |
|---|---|---|
| Primer artículo | EUR 35,00 | EUR 45,00 |
Métodos de pago
- Cheque
- Giro bancario
- PayPal
Descripción de la tienda
Das Unternehmen AHA-BUCH GmbH: Seit der Gründung von AHA-BUCH im Juli 2005 ist unser Hauptziel, zufriedenen Kunden so schnell und so preisgünstig wie möglich ihren Bücherwunsch zu erfüllen. Unsere Firma beschäftigt 16 Mitarbeiter, die nur ein Ziel kennen: den Kunden und seine Wünsche! Auf über 3700 m2 Fläche haben wir über 100.000 Bücher, Modernes Antiquariat und Spiele auf Lager.
Especialidad
Kinderbücher & Kinderhör Casetten, German Books, Software, Natur & Tiere, Ratgeber, Sachbücher, Englische Bücher, Medizin & Gesundheit, Universität & StudiumInformación empresarial del vendedor
AHA-BUCH GmbH
Garlebsen 48
Einbeck, Alemania 37574
Condiciones de venta
IImprint
Información del vendedor
AHA-BUCH GmbH
representado por el director gerente Christel Glass
Garlebsen 48
37574 Einbeck
Alemania
Teléfono: 055639996039
Fax: 055639995974
E-Mail: abebooks@aha-buch.de
USt-IdNr.: DE261904229
Inscrita en el Registro Mercantil Amtsgerichtes Göttingen
Handelsregisternummer HRB 200691
Resolución alternativa de conflictos:
La Comisión Europea proporciona una plataforma para la resolución extrajudicial de litigios en línea (plataforma ODR), a la que se puede acceder en https://ec.europa.eu/odr.
Somos miembros de la iniciativa "FairCommerce" desde el 25.05.2018.
Para obtener más información, consulte www.fair-commerce.de.
Derecho al desistimiento
Si es un consumidor, puede rescindir el contrato de acuerdo con lo siguiente. Por consumidor se entiende cualquier persona física que actúe con fines ajenos a su actividad comercial, empresarial, oficio o profesión.
Información sobre el derecho de desistimiento
Derecho legal de desistimiento
Tiene derecho a rescindir este contrato en un plazo de 14 días sin dar ningún motivo.
El periodo de desistimiento vencerá a los 14 días desde que usted, o un tercero que no sea el transportista e indicado por usted, adquiera la posesión física del último bien o del último lote o pieza.
Para ejercer el derecho de desistimiento, complete de forma electrónica y envíe una declaración clara en nuestro sitio web, desde "Mis compras" en "Mi cuenta". Le enviaremos sin demora un acuse de recibo de dicho desistimiento a través de un soporte duradero (por ejemplo, por correo electrónico).
Para cumplir con el plazo de desistimiento, basta con que envíe su comunicación relativa al ejercicio del derecho de desistimiento antes de que venza el periodo de desistimiento.
Efectos del desistimiento
Si rescinde este contrato, le reembolsaremos todos los pagos que hayamos recibido de usted, incluidos los gastos de envío (excepto los gastos adicionales que surjan si elige un tipo de envío que no sea el tipo de envío estándar más económico que ofrecemos).
Podemos hacer una deducción del reembolso por la pérdida de valor de cualquier bien suministrado, si la pérdida es el resultado de una manipulación innecesaria por su parte.
Efectuaremos el reembolso sin demoras indebidas y, a más tardar, 14 días después de que se nos informe de su decisión de rescindir este contrato.
Efectuaremos el reembolso utilizando el mismo medio de pago que utilizó para la transacción inicial, a menos que haya acordado expresamente lo contrario; en cualquier caso, no incurrirá en ningún cargo como resultado de dicho reembolso.
Podremos retener el reembolso hasta que hayamos recibido los bienes o hasta que nos haya presentado una prueba de que los ha devuelto, lo que ocurra primero.
Deberá devolver los bienes o entregarlos a AHA-BUCH GmbH, Einbeck, Germany, sin demoras indebidas y, en cualquier caso, en un plazo máximo de 14 días a partir del día en que nos comunique su desistimiento del presente contrato. El plazo se cumple si devuelve la mercancía antes de que venza el periodo de 14 días. Tendrá que asumir los gastos directos de devolución de los bienes. Usted solo es responsable de la disminución del valor de los bienes como resultado de una manipulación distinta a la necesaria para establecer la naturaleza, las características y el funcionamiento de los bienes.
Excepciones al derecho de desistimiento
El derecho de desistimiento no se aplica a lo siguiente:
- La entrega de periódicos, diarios o revistas, con la excepción de los contratos de suscripción; y
- El suministro de contenido digital que no se proporcione en un soporte tangible (por ejemplo, en un CD o DVD) si, al hacer el pedido, aceptó que podíamos empezar a entregarlo y que no podría desistir una vez iniciada la entrega.
Condiciones de envío
Enviamos su pedido después de recibirlos
para artículos disponibles las últimas 24 horas,
para artículos con suministro nocturno a más tardar 48 horas.
En caso de que necesitemos pedir un artículo a nuestro proveedor, nuestro tiempo de envío depende de la fecha de recepción de los artículos, pero los artículos se enviarán el mismo día.
Nuestro objetivo es enviar los artículos pedidos de la manera más rápida, pero también más eficiente y segura a nuestros clientes.